Does Interleukin-17A Blockade Have a Potential Clinical Role to Reduce Cardiovascular Risk in Psoriasis?

Affiliations

¹ Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, ON, Canada. Electronic address: subodh.verma@unityhealth.to.
² Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA.

Editorial

Subodh Verma et al. Can J Cardiol. 2020 Jan.

. 2020 Jan;36(1):24-26.

doi: 10.1016/j.cjca.2019.11.011. Epub 2019 Nov 16.

¹ Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, ON, Canada. Electronic address: subodh.verma@unityhealth.to.
² Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA.

No abstract available

Comment on

Effects of Interleukin 17A Inhibition on Myocardial Deformation and Vascular Function in Psoriasis.
Makavos G, Ikonomidis I, Andreadou I, Varoudi M, Kapniari I, Loukeri E, Theodoropoulos K, Pavlidis G, Triantafyllidi H, Thymis J, Parissis J, Tsoumani M, Rafouli-Stergiou P, Katsimbri P, Papadavid E. Makavos G, et al. Can J Cardiol. 2020 Jan;36(1):100-111. doi: 10.1016/j.cjca.2019.06.021. Epub 2019 Jun 26. Can J Cardiol. 2020. PMID: 31606265 Clinical Trial.